Siddiqui et al., 2015 - Google Patents
Muscle paralysis in thyrotoxicosisSiddiqui et al., 2015
View PDF- Document ID
- 11619265528126767274
- Author
- Siddiqui F
- Sheikh A
- Publication year
- Publication venue
- BMJ Case Reports CP
External Links
Snippet
Thyrotoxic periodic paralysis (TPP) is a condition characterised by muscle paralysis due to hypokalaemia usually secondary to thyrotoxicosis. We report a case of a 31-year-old man with no known comorbidities who presented to a tertiary healthcare unit with a 1-month …
- 210000003205 Muscles 0 title abstract description 16
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lily et al. | Treating prediabetes with metformin: systematic review and meta-analysis | |
| Carrico et al. | Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization | |
| Mitchell et al. | How should we treat patients with low serum thyrotropin concentrations? | |
| Strain et al. | Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL study | |
| Chang et al. | Evaluating the efficacy of primary treatment for Graves’ disease complicated by thyrotoxic periodic paralysis | |
| Kusuki et al. | Hungry bone syndrome after thyroidectomy for thyroid storm | |
| Siddiqui et al. | Muscle paralysis in thyrotoxicosis | |
| Sinharay | Hypokalaemic thyrotoxic periodic paralysis in an Asian man in the United Kingdom | |
| Albert et al. | QT prolongation in a child with thyroid storm | |
| Portelli et al. | Amiodarone-induced type 2 thyrotoxicosis | |
| Ray et al. | An unusual cause of muscle weakness: a diagnostic challenge for clinicians | |
| Matta et al. | Thyrotoxic hypokalaemic periodic paralysis: a rare presentation of Graves’ disease in a Hispanic patient | |
| Khan et al. | Amiodarone-induced thyrotoxicosis: type 1 or type 2? | |
| Shukla et al. | Subcutaneous oedema of upper limbs heralding an aggressive form of dermatomyositis | |
| Chong et al. | Pseudohypoparathyroidism: a rare but important cause of hypocalcaemia | |
| Sanyal et al. | Three cases of thyrotoxic periodic paralysis due to painless thyroiditis | |
| Gibelli et al. | Thyroid cancer: possible role of telemedicine | |
| Lybecker et al. | Severe hypokalaemia as a cause of acute transient quadriparesis | |
| Elenius et al. | Thyrotoxic periodic paralysis causing back pain and leg weakness: An unusual presentation of hyperthyroidism | |
| Shah et al. | A woman who lost weight at the cost of her heartbeat | |
| Paudyal et al. | Spontaneous hypoglycaemia in a patient with Graves' disease | |
| Tariq et al. | Sudden flaccid paralysis | |
| Dal Bo et al. | Young man with acute flaccid tetraparesis | |
| Ueda et al. | Type 2 diabetes mellitus complicated with idiopathic hypoparathyroidism where poor glycaemic control was associated with low adherence to exercise and medication due to hypocalcaemia | |
| Gilmartin et al. | Teenage kicks: splenic rupture secondary following infectious mononucleosis |